Results 51 to 60 of about 786,683 (318)

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Preventing perinatal transmission is important for hepatitis B (HepB) elimination. We conducted a retrospective cohort study to assess the interval between HepB birth-dose (HepB-BD) to second-dose (HepB-SD) vaccination on perinatal transmission. Among 39,
Tae Un Yang   +5 more
doaj   +1 more source

Distributed personnel scheduling—negotiation among scheduling agents [PDF]

open access: yesAnnals of Operations Research, 2007
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Kaplansky, Eliezer, Meisels, Amnon
openaire   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Irrigation Scheduling as a Tool to Improve the Water Use Efficiency for Cherries Plants

open access: yesمجلة النهرين للعلوم الهندسية, 2017
Methods for scheduling irrigation are important aspects of good crop and plant management. Irrigation scheduling process is concerned with quantity and date of irrigation.
Sabah Anwer Dawood Almasraf   +1 more
doaj  

Virtual Cluster Scheduling Through the Scheduling Graph [PDF]

open access: yesInternational Symposium on Code Generation and Optimization (CGO'07), 2007
Peer ...
Codina Viñas, Josep M.   +2 more
openaire   +2 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

La mesure du temps de travail

open access: yesSociologies, 2013
This paper deals with the methodology of time-budget studies for the measurement of time devoted to work. It relies on five Canadian studies made between 1986 and 2010, three French studies made in the same year as some Canadian surveys as well as three ...
Gilles Pronovost
doaj  

ON DECOMPOSITION OF PROBLEM OF CONSTRUCTING THE AGREED TIMETABLE IN PROJECT ACTIVITIES

open access: yesСтатистика и экономика, 2016
Most productions scheduling problems in the planning of operations or worksdo not consider the factor of activity associated with the project activities ofindividual agents. Based on the elements of an open (agreed) managementand to promote the theory of
Alexey S. Dobrynin   +2 more
doaj   +1 more source

Engagement of hospital pharmacists and technicians to optimize staffing schedules

open access: yesJournal of Pharmaceutical Policy and Practice, 2021
Challenges exist in developing work schedules for hospital pharmacy staff due to the need to meet around the clock patient care requirements. Work–life integration and reduced burnout are increasingly important considerations in staff schedules. However,
Jessica Wright   +4 more
doaj   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy